Presentation TCT 2012 The New Anticoagulants: A Meaningful Step Forward? Presenter: Gregg Stone October 23, 2012
Presentation TCT 2012 TCT-52. Bivalirudin Reduces Cardiac Mortality in Patients with and Without Major Bleeding: The HORIZONS-AMI Trial Presenter: Gregg Stone October 23, 2012
Presentation TCT 2012 Introductory Lecture. A New Paradigm Revisited: From Ischemia to Vulnerable Plaque Presenter: Gregg Stone October 23, 2012
News Conference News TCT 2012 VERDICT/F1RST Confirms Modest Correlation Between IVUS, MLA and FFR October 23, 2012
Presentation TCT 2012 ABSORB III and IV (Abbott Vascular) Pivotal Clinical Trial Program Presenter: Gregg Stone October 23, 2012
Presentation TCT 2012 What Definition Should Be Used to Define Periprocedural MI in Clinical Trials and Practice? Presenter: Gregg Stone October 22, 2012
Presentation TCT 2012 Longitudinal Stent Deformation One Year Later: How Important an Issue Is This? Presenter: Gregg Stone October 22, 2012
Presentation TCT 2012 Everolimus-Eluting Stents: SPIRIT and PLATINUM Update Presenter: Gregg Stone October 22, 2012
Presentation TCT 2012 VERDICT/FIRST: Prospective, Multicenter Study Examining the Correlation between IVUS and FFR Parameters in Intermediate Lesions Presenter: Gregg Stone October 22, 2012
Presentation TCT 2012 The EXCEL Trial: Novel Aspects and Status Update Presenter: Gregg Stone October 22, 2012
News Conference News TCT 2012 Israeli Innovations Include ‘Cath Lab of the Future,’ Stent and Digital Developments October 22, 2012
News Daily News La Bivalirudina Reduce las Hemorragias en Pacientes NSTEMI sometidos a PCI Jason Kahn October 19, 2012
News Daily News Bivalirudin Lowers Bleeding in NSTEMI Patients Undergoing PCI Jason Kahn October 19, 2012
Presentation Optimal Anticoagulant/Antiplatelet Therapy in Challenging Subsets: A Post-ESC Late Breaking Trial Roundup Presenter: 62744|Gregg Stone September 18, 2012